Studies focusing on the role of FSH have found that, in vitro, it could not only stimulate the growth of normal or immortalized ovarian surface epithelial cells but also accelerate some ovarian cancer cell growth in a time-dependent and dose-dependent manner. This evidence concerns the gene BRD2 and ovarian carcinoma.